JPRN-UMIN000010113
Not Yet Recruiting
Phase 1
A phase II clinical trial of neoadjyvant chemoradiation therapy using Gemcitabine combined with IMRT for borderline resectable pancreatic cancer - Neoadjuvant chemoradiation therapy for locally advanced pancreatic cancer
Hepato-pamcreato-biliary Surgery and Transplantation, Graduate School of Medicine and Faculty of Medicine KyotoUniversity0 sites37 target enrollmentMarch 1, 2013
Conditionsborderline resectable pancreatic cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- borderline resectable pancreatic cancer
- Sponsor
- Hepato-pamcreato-biliary Surgery and Transplantation, Graduate School of Medicine and Faculty of Medicine KyotoUniversity
- Enrollment
- 37
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with lung fibrosis or interstitional pneumonia 2\) Patients who can not underwent radiation therapy because of past radiation therapy 3\) Severe co\-morbid diseases 4\) Intractable pleural and pericardical effusion, or ascites 5\) Patients with other active cancers 6\)Pregnancy or insufficient contraception 7\) severe mental illness 8\) Patients seems inadequate for this study by investigator(s)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A phase II clinical trial of neoadjuvant chemoradiation therapy for pancreatic ductal adenocarcinomapancreatic cancerJPRN-UMIN000035232Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University50
Recruiting
Phase 2
A clinical phase-II trial of neoadjuvant chemoradiotherapy with S-1 and Gemcitabine for locally advanced pancreatic cancer (PerSeUS-GP02)ocally advanced pancreatic cancerJPRN-UMIN000010435PerSeUS: Perpetual Study estimated-by United Sections in gifu40
Completed
Phase 2
A clinical phase-II trial of neoadjuvant chemoradiation therapy using S-1 for locally advanced pancreatic cancer (PerSeUS-GP-01)ocally advanced pancreatic cancerJPRN-UMIN000002176PerSeUS-GP40
Not Yet Recruiting
N/A
Phase 2 clinical study of neoadjuvant chemotherapy for HER2-negative primary breast cancer patients using dose dense nab-paclitaxel followed by dose dense Epirubicin and cyclophosphamideHER2 negative primary breast cancerJPRN-UMIN000019787Dept of breast oncology50
Completed
Phase 2
Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinomaoral squamous cell carcinomaJPRN-C000000023Chubu research group on oral cancer30